Evista and insurance coverage: what to expect — for South Korea
Whether Evista (Raloxifene) is covered by insurance or a public health system depends on the medication, the formulary tier, and the patient's contribution group or plan. For chronic use of Evista at 60mg, coverage is usually the dominant economic factor — far more than the official retail price.
South Korea context
Coverage of Evista in South Korea depends on the public system, the private insurer or the pharmacy benefit. In South Korea, prescription medicines (전문의약품) are dispensed only against a doctor's prescription, while general medicines (일반의약품) are sold OTC at pharmacies. The 2000 medical reform separated dispensing from prescribing — doctors prescribe, pharmacists dispense. Authorised generics of Raloxifene are usually preferred-tier and lower-cost; branded Evista sits at a higher tier or may require prior authorisation. Out-of-pocket cost in KRW can vary substantially between plans.
- Regulator
- MFDS (Ministry of Food and Drug Safety)
- Currency
- KRW
How coverage works
Most insurers and public systems use a formulary that lists which medications are covered, at which tier (preferred generic, preferred brand, non-preferred, specialty), and with what out-of-pocket contribution. Evista sits somewhere on this list depending on whether the active ingredient Raloxifene has authorised generics, the negotiated price and the system's cost-effectiveness assessment for Hormones and Birth Control.
Practical considerations
According to general health-insurance practice, prior authorisation is sometimes required before Evista is covered — particularly for the brand version when an authorised generic exists. Step therapy may require trying a generic first. The pharmacist can usually confirm whether a specific Evista prescription is covered and what the patient pays, often before the prescription is dispensed at 60mg.
Frequently asked questions
Is Evista covered by insurance? ▾
Coverage of Evista depends on the specific insurer or public system, the formulary tier and any prior-authorisation rules. Authorised generics of Raloxifene are typically covered at the lowest cost tier, while branded Evista sits on a higher tier with more out-of-pocket spend.
How much will Evista cost out of pocket? ▾
Out-of-pocket cost depends on the plan tier, deductible status and copay. Authorised generics of Raloxifene usually cost a fraction of the brand. The pharmacy can run the prescription against the plan and quote the actual price for Evista at 60mg before dispensing.
Evista and insurance coverage: what to expect in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.